首页> 美国政府科技报告 >IMPACT (Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets and Complementary, Innovative and Therapeutic Modalities); Annual rept. 1 Feb 2005-31 Jan 2006
【24h】

IMPACT (Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets and Complementary, Innovative and Therapeutic Modalities); Annual rept. 1 Feb 2005-31 Jan 2006

机译:影响(肺癌患者的影像和分子标记:分子靶点和补充,创新和治疗方式的方法);年度报告。 2005年2月1日至2006年1月31日

获取原文

摘要

The projects in this proposal specifically target several signal transduction pathways known to be critical for NSCLC pathogenesis including the EGFR pathway and the more downstream ras/raf/Mek/ERK pathway. These projects combine targeted approaches using molecular and imaging techniques to validate activity against a target and monitor response using imaging modalities specific to the receptor using either small molecules or targeted peptlde approaches. The Developmental Research projects explore new areas including (1) the issue of high morbidity malignant pleural effusion thereby bringing the pulmonologists into the treatment of advanced disease with molecular therapies; and (2) prevention of lung cancer in youth through a highly interactive, entertaining CD-ROM program.

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号